Navigation Links
Endo to Present at the 2011 RBC Capital Markets Healthcare Conference
Date:2/11/2011

CHADDS FORD, Pa., Feb. 11, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the 2011 RBC Capital Markets Healthcare Conference on Wednesday, March 2, 2011 at 10:30 a.m. ET.  Blaine Davis, vice president, corporate affairs of Endo, will review the company's products and development programs.

The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section.  

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit www.endo.com.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
2. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. Symmetry Medical to Present at Canaccord Genuitys Musculoskeletal Conference
5. NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials
6. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
7. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
8. Telik Announces Presentation and Webcast at 13th Annual BIO CEO & Investor Conference
9. NeurogesX to Present at Two February Investor Conferences
10. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
11. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... N.H. , March 27, 2017  iCAD ... analysis, workflow solutions and radiation therapy for the ... that PowerLook® Tomo Detection received Premarket Approval (PMA) ... PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer ... and is the latest innovation available on the ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... AUSTIN, Texas , March 27, 2017   Genprex, Inc. ... announced that Julien Pham , MD, the Company,s Chief Operating ... healthcare investor conferences. Sachs 5th Annual Cancer BioPartnering ... in New York, NY ... BioCentury 24th Annual Future Leaders ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Conference in Atlantic City March 13-16, was a busy spot this year. Liz ... staff discussed strategies for preventing outbreaks among camp communities during the upcoming 2017 ...
(Date:3/28/2017)... ... ... you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium in beautiful ... offered an opportunity to collaborate and network with healthcare colleagues across the United States. ... for a lively discussion on trends and issues that healthcare leaders will face in ...
(Date:3/27/2017)... CO (PRWEB) , ... March 27, 2017 , ... New ... Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep apnea ... condition, which can include daytime sleepiness, morning headaches and chronic snoring. , Dr. ...
(Date:3/27/2017)... NY (PRWEB) , ... March 27, 2017 , ... Drs. ... Canal Awareness Week by teaching their patients about the key role this treatment plays ... therapy from an experienced endodontist. To better serve those who need a root canal ...
Breaking Medicine News(10 mins):